The antihypertensive treatment effect on left ventricular diastolic function is reflected in exercise electrocardiogram

Journal of Electrocardiology

Volumn 45, Issue 1, 2012, Pages 28-35

  Liakos, Charalampos I ^a   Michaelides, Andreas P ^a   Vyssoulis, Gregory P ^a   Chatzistamatiou, Evaggelos I ^a   Dilaveris, Polychronis E ^a   Markou, Maria I ^b   Stefanadis, Christodoulos I ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b 417 VA Hospital (NIMTS)   (Greece)

Author keywords

Antihypertensive pharmacological treatment; Arterial hypertension; Exercise testing; False positive result; Hump sign; Left ventricular diastolic function; Left ventricular geometry; Left ventricular hypertrophy; ST segment depression

Indexed keywords

DILTIAZEM; HYDROCHLOROTHIAZIDE; IRBESARTAN;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC DYSFUNCTION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; EXERCISE ELECTROCARDIOGRAPHY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; TISSUE DOPPLER IMAGING; TREADMILL ERGOMETRY; TREATMENT RESPONSE;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84855310456     PISSN: 00220736     EISSN: 15328430     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2011.07.014     Document Type: Article

References (20)

1. Ellestad MH. ECG patterns and their significance. False positive ST changes. Convex ST segment depression-hump sign. In: Ellestad MH, editor. 5th ed. New York: Oxford University Press; 2003. p. 189.
2. Pippin JJ, Devers SM, Buckner DJ, Weilbacher DC, Kettles MA. The ST hump sign: a reliable indicator for false positive electrocardiographic response during treadmill exercise. Circulation 2000;102 (suppl 2):394.
3. Sapin PM, Koch G, Blauwet MB, McCarthy JJ, Hinds SW, Gettes LS. Identification of false positive exercise tests with use of electrocardiographic criteria: a possible role for atrial repolarization waves. J Am Coll Cardiol 1991;18:127.
4. Sapin PM, Blauwet MB, Koch GG, Gettes LS. Exaggerated atrial repolarization waves as a predictor of false positive exercise tests in an unselected population. J Electrocardiol 1995;28:313.
5. Michaelides AP, Raftopoulos LG, Aggeli C, et al. Correlation of ST-segment "hump sign" during exercise testing with impaired diastolic function of the left ventricle. J Electrocardiol 2010;43:167.
6. Michaelides AP, Stamatopoulos I, Antoniades C, et al. ST segment "hump" during exercise testing and the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. Ann Noninvasive Electrocardiol 2009;14:158.
7. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens 2008;21:500.
8. Gradman AH, Wilson JT. Hypertension and diastolic heart failure. Curr Cardiol Rep 2009;11:422.
9. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). ACC Web site. Available at: www.acc.org/clinical/guidelines/exercise/ dirIndex.htm.
10. Picano E, Pálinkás A, Amyot R. Diagnosis of myocardial ischemia in hypertensive patients. J Hypertens 2001;19:1177.
11. Das A, Abraham S, Deswal A. Advances in the treatment of heart failure with a preserved ejection fraction. Curr Opin Cardiol 2008;23:233.
12. Falcão-Pires I, Leite-Moreira AF. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev 2011, doi:10.1007/s10741-011-9257-z [epub ahead of print].
13. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105.
14. D'Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 2008;117:743.
15. Conroy RM, Pyörälä K, Fitzgerald A, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987.
16. Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381.
17. Kavouras SA, Panagiotakos DB, Pitsavos C, et al. Physical activity, obesity status, and glycemic control: the ATTICA study. Med Sci Sports Exerc 2007;39:606.
18. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10:165.
19. Shah RV, Desai AS, Givertz MM. The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis. J Card Fail 2010;16:260.
20. Tapp RJ, Sharp A, Stanton AV, et al. Differential effects of antihypertensive treatment on left ventricular diastolic function. An ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy. J Am Coll Cardiol 2010;55:1875.